Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The FDA approved a new Pfizer drug for hair loss in teens.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Finasteride may cause kidney damage.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

ITK inhibitors may effectively treat alopecia areata.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Ketoconazole is effective for treating various fungal infections and has new uses in dermatology, but oral use can have serious side effects.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Compound 15a was effective in inhibiting 5α-reductase.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

The combination treatment showed a higher response rate but no significant survival benefits.